Company intelligence / Profile preview

Plus India Formulation

Karnal, Haryana, India

Ownership: Private
Development stage: Other

Overview

Plus India Formulations is an Indian pharmaceutical company focused on the manufacturing and marketing of a wide range of finished dosage forms. The company's product portfolio includes antibiotics, analgesics, anti-inflammatory agents, and nutritional supplements, primarily in oral solid and liquid forms. They operate as a generic pharmaceutical player, catering to the domestic Indian market with a focus on providing affordable healthcare solutions. The company is involved in both direct marketing and potentially contract manufacturing services for various therapeutic segments.

Therapeutic areas: ImmunologyNeurologyInfectious DiseasesGastroenterologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Plus India Formulation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plus India Formulation.

Explore the full profile